Sixth Veterinary Big Data Stakeholder Forum, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2026, 13:00 (CET) to 10 November 2026, 17:30 (CET)

Sixth Veterinary Big Data Stakeholder Forum, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2026, 13:00 (CET) to 10 November 2026, 17:30 (CET)

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised

Workshop on advancing proof-of-concept data in paediatric oncology drug development , Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 September 2026, 13:00 (CEST) to 21 September 2026, 16:00 (CEST)

Workshop on advancing proof-of-concept data in paediatric oncology drug development , Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 September 2026, 13:00 (CEST) to 21 September 2026, 16:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.